Shopping Cart
Remove All
Your shopping cart is currently empty
Thalidomide-O-C2-acid, designed by synthesizing an E3 ligase ligand-linker conjugate, comprises a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $696 | 35 days | 35 days |
| Description | Thalidomide-O-C2-acid, designed by synthesizing an E3 ligase ligand-linker conjugate, comprises a cereblon ligand derived from Thalidomide and a linker commonly used in PROTAC technology. |
| In vitro | PROTACs consist of two distinct ligands joined by a linker; one ligand targets an E3 ubiquitin ligase, while the other targets the desired protein. They utilize the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2]. |
| Synonyms | Thalidomide-O-C2-acid |
| Molecular Weight | 346.2916 |
| Formula | C16H14N2O7 |
| Cas No. | 2369068-42-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.